Drugs / FIMASARTAN POTASSIUM TRIHYDRATE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01289899 | Jan → Feb 2004 | essential hypertension | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01289886 | Sep → Nov 2003 | essential hypertension | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FIMASARTAN POTASSIUM TRIHYDRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297548 ↗ |
| Known as | BR-A-657 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01289886 ↗ |
| Route | Oral | “Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects” NCT01289886 ↗ |